Brokers Offer Predictions for Vital Farms Q2 Earnings

Vital Farms, Inc. (NASDAQ:VITL) – Equities researchers at Telsey Advisory Group dropped their Q2 2025 earnings per share estimates for shares of Vital Farms in a research report issued to clients and investors on Friday, May 9th. Telsey Advisory Group analyst S. Vora now anticipates that the company will post earnings of $0.27 per share for the quarter, down from their prior estimate of $0.28. Telsey Advisory Group has a “Outperform” rating and a $52.00 price objective on the stock. The consensus estimate for Vital Farms’ current full-year earnings is $1.11 per share. Telsey Advisory Group also issued estimates for Vital Farms’ Q4 2025 earnings at $0.36 EPS, FY2025 earnings at $1.26 EPS and FY2026 earnings at $1.52 EPS.

VITL has been the subject of a number of other reports. William Blair reissued an “outperform” rating on shares of Vital Farms in a report on Friday, February 28th. BMO Capital Markets upgraded Vital Farms to a “strong-buy” rating in a research note on Tuesday, May 6th. Morgan Stanley cut their target price on Vital Farms from $40.00 to $39.00 and set an “overweight” rating on the stock in a research note on Thursday, April 17th. DA Davidson cut their target price on Vital Farms from $44.00 to $42.00 and set a “buy” rating on the stock in a research note on Friday, March 14th. Finally, Stifel Nicolaus upgraded Vital Farms from a “hold” rating to a “buy” rating and set a $44.00 price objective on the stock in a research note on Friday, February 28th. Eight research analysts have rated the stock with a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Buy” and a consensus price target of $44.63.

Vital Farms Stock Performance

Shares of VITL opened at $33.82 on Monday. The company has a debt-to-equity ratio of 0.04, a quick ratio of 2.81 and a current ratio of 3.24. The stock has a 50 day moving average price of $32.50 and a two-hundred day moving average price of $35.07. The firm has a market capitalization of $1.51 billion, a P/E ratio of 30.20 and a beta of 0.94. Vital Farms has a 52 week low of $27.91 and a 52 week high of $48.41.

Vital Farms (NASDAQ:VITL) last issued its quarterly earnings data on Thursday, May 8th. The company reported $0.37 EPS for the quarter, topping analysts’ consensus estimates of $0.26 by $0.11. The firm had revenue of $162.19 million during the quarter, compared to analyst estimates of $164.43 million. Vital Farms had a return on equity of 22.29% and a net margin of 8.68%. The company’s revenue for the quarter was up 9.7% on a year-over-year basis. During the same period in the previous year, the company posted $0.43 EPS.

Insiders Place Their Bets

In other Vital Farms news, insider Matthew Ohayer sold 24,000 shares of the stock in a transaction on Monday, April 21st. The stock was sold at an average price of $32.68, for a total transaction of $784,320.00. Following the sale, the insider now owns 6,942,890 shares in the company, valued at $226,893,645.20. This represents a 0.34% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, CEO Russell Diez-Canseco sold 45,124 shares of the stock in a transaction on Monday, April 14th. The stock was sold at an average price of $33.69, for a total value of $1,520,227.56. Following the sale, the chief executive officer now owns 703,736 shares in the company, valued at approximately $23,708,865.84. This represents a 6.03% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 93,124 shares of company stock worth $3,019,308 over the last 90 days. Corporate insiders own 27.60% of the company’s stock.

Institutional Investors Weigh In On Vital Farms

Institutional investors have recently made changes to their positions in the stock. Nordea Investment Management AB purchased a new stake in shares of Vital Farms during the fourth quarter worth $2,765,000. JPMorgan Chase & Co. raised its position in shares of Vital Farms by 38.9% in the third quarter. JPMorgan Chase & Co. now owns 266,398 shares of the company’s stock worth $9,343,000 after buying an additional 74,593 shares in the last quarter. Proficio Capital Partners LLC purchased a new stake in shares of Vital Farms in the fourth quarter worth $699,000. Franklin Resources Inc. raised its position in shares of Vital Farms by 10.2% in the third quarter. Franklin Resources Inc. now owns 372,583 shares of the company’s stock worth $13,066,000 after buying an additional 34,412 shares in the last quarter. Finally, Barclays PLC raised its position in shares of Vital Farms by 57.3% in the third quarter. Barclays PLC now owns 95,444 shares of the company’s stock worth $3,347,000 after buying an additional 34,758 shares in the last quarter. Hedge funds and other institutional investors own 98.59% of the company’s stock.

Vital Farms Company Profile

Vital Farms, Inc, a food company, provides pasture-raised products in the United States. It offers shell eggs, butter, hard-boiled eggs, and liquid whole eggs. The company was founded in 2007 and is headquartered in Austin, Texas.